首页> 美国卫生研究院文献>Environmental Health Perspectives >Comparative metabolism of chloroacetamide herbicides and selected metabolites in human and rat liver microsomes.
【2h】

Comparative metabolism of chloroacetamide herbicides and selected metabolites in human and rat liver microsomes.

机译:人和大鼠肝脏微粒体中氯乙酰胺除草剂和某些代谢物的比较代谢。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Acetochlor [2-chloro-N-(ethoxymethyl)-N-(2-ethyl-6-methyl-phenyl)-acetamide], alachlor [N-(methoxymethyl)-2-chloro-N-(2, 6-diethyl-phenyl)acetamide], butachlor [N-(butoxymethyl)-2-chloro-N-(2,6-diethyl-phenyl)acetamide], and metolachlor [2-chloro-N-(2-ethyl-6-methylphenyl)-N-(2-methoxy-1-methylethyl) acetamide] are pre-emergent herbicides used in the production of agricultural crops. These herbicides are carcinogenic in rats: acetochlor and alachlor cause tumors in the nasal turbinates, butachlor causes stomach tumors, and metolachlor causes liver tumors. It has been suggested that the carcinogenicity of these compounds involves a complex metabolic activation pathway leading to a DNA-reactive dialkylbenzoquinone imine. Important intermediates in this pathway are 2-chloro-N-(2,6-diethylphenyl)acetamide (CDEPA) produced from alachlor and butachlor and 2-chloro-N-(2-methyl-6-ethylphenyl)acetamide (CMEPA) produced from acetochlor and metolachlor. Subsequent metabolism of CDEPA and CMEPA produces 2,6-diethylaniline (DEA) and 2-methyl-6-ethylaniline (MEA), which are bioactivated through para-hydroxylation and subsequent oxidation to the proposed carcinogenic product dialkylbenzoquinone imine. The current study extends our earlier studies with alachlor and demonstrates that rat liver microsomes metabolize acetochlor and metolachlor to CMEPA (0.065 nmol/min/mg and 0.0133 nmol/min/mg, respectively), whereas human liver microsomes can metabolize only acetochlor to CMEPA (0.023 nmol/min/mg). Butachlor is metabolized to CDEPA to a much greater extent by rat liver microsomes (0.045 nmol/min/mg) than by human liver microsomes (< 0.001 nmol/min/mg). We have determined that both rat and human livers metabolize both CMEPA to MEA (0.308 nmol/min/mg and 0.541 nmol/min/mg, respectively) and CDEPA to DEA (0.350 nmol/min/mg and 0.841 nmol/min/mg, respectively). We have shown that both rat and human liver microsomes metabolize MEA (0.035 nmol/min/mg and 0.069 nmol/min/mg, respectively) and DEA (0.041 nmol/min/mg and 0.040 nmol/min/mg, respectively). We have also shown that the cytochrome P450 isoforms responsible for human metabolism of acetochlor, butachlor, and metolachlor are CYP3A4 and CYP2B6.
机译:乙草胺[2-氯-N-(乙氧基甲基)-N-(2-乙基-6-甲基-苯基)-乙酰胺],甲草胺[N-(甲氧基甲基)-2-氯-N-(2,6-二乙基-苯基]乙酰胺],丁草胺[N-(丁氧基甲基)-2-氯-N-(2,6-二乙基-苯基)乙酰胺]和甲草胺[2-氯-N-(2-乙基-6-甲基苯基)- N-(2-甲氧基-1-甲基乙基)乙酰胺]是用于农作物生产的芽前除草剂。这些除草剂在大鼠中具有致癌作用:乙草胺和甲草胺会引起鼻甲鼻甲肿瘤,丁草胺会引起胃部肿瘤,而甲草胺会引起肝脏肿瘤。已经表明这些化合物的致癌性涉及导致DNA反应性二烷基苯醌亚胺的复杂的代谢活化途径。该途径中的重要中间体是由甲草胺和丁草胺生产的2-氯-N-(2,6-二乙基苯基)乙酰胺(CDEPA)和由甲草胺生产的2-氯-N-(2-甲基-6-乙基苯基)乙酰胺(CMEPA)乙草胺和异丙甲草胺。 CDEPA和CMEPA的后续代谢产生了2,6-二乙基苯胺(DEA)和2-甲基-6-乙基苯胺(MEA),它们通过对羟基化并随后氧化为拟议的致癌产物二烷基苯醌亚胺而被生物活化。当前的研究扩展了我们较早前对草甘膦的研究,并表明大鼠肝脏微粒体将乙草胺和甲草胺代谢为CMEPA(分别为0.065 nmol / min / mg和0.0133 nmol / min / mg),而人肝微粒体只能将乙草胺代谢为CMEPA( 0.023 nmol / min / mg)。与人肝微粒体(<0.001 nmol / min / mg)相比,大鼠肝脏微粒体(0.045 nmol / min / mg)将丁草胺代谢成CDEPA的程度更大。我们已经确定,大鼠和人类肝脏均将CMEPA代谢为MEA(分别为0.308 nmol / min / mg和0.541 nmol / min / mg)和CDEPA为DEA(0.350 nmol / min / mg和0.841 nmol / min / mg),分别)。我们已经显示,大鼠和人肝微粒体都代谢MEA(分别为0.035 nmol / min / mg和0.069 nmol / min / mg)和DEA(分别为0.041 nmol / min / mg和0.040 nmol / min / mg)。我们还显示负责人乙草胺,丁草胺和甲草胺代谢的细胞色素P450亚型是CYP3A4和CYP2B6。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号